RxDoctor Payments Data

Neville Crenshaw, DO

Family Medicine · Kahoka, MONPI 1316994783

Payments from drug & device makers

$962in general payments, 2019–2025

Across 64 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$233
  • Pfizer$141
  • Amgen$129
  • GSK$108
  • Lilly USA, LLC$98
  • AstraZeneca$60
  • plus $193 from 9 others

What the payments were for

  • Food & beverage$94798%
  • Education$152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$962 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$17,536
Medicare patients
210
Services billed
1,924

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter89$83,564
EliquisApixaban85$70,537
OzempicSemaglutide68$64,733
MounjaroTirzepatide43$46,439
JanuviaSitagliptin Phosphate54$39,923
XareltoRivaroxaban27$30,492
TrulicityDulaglutide17$24,567
MyrbetriqMirabegron18$23,914
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog30$20,046
LinzessLinaclotide17$17,139
Repatha SureclickEvolocumab16$15,908
JardianceEmpagliflozin16$14,984
Tresiba Flextouch U-100Insulin Degludec19$14,753
EntrestoSacubitril/Valsartan16$12,333
FarxigaDapagliflozin Propanediol11$10,418

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$108$83,56489 claims
Lilly USA, LLCMounjaro, Trulicity$98$71,00760 claims
PfizerEliquis$141$70,53785 claims
Novo NordiskOzempic$35$64,73368 claims
Astellas Pharma US IncMyrbetriq$18$23,91418 claims
AbbVieLinzess$233$17,13917 claims
AstraZenecaFarxiga, Bevespi Aerosphere$60$15,30922 claims
Boehringer IngelheimJardiance$12$14,98416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Kahoka

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →